Skip to main content
. 2021 Aug 29;144(15):1196–1211. doi: 10.1161/CIRCULATIONAHA.121.056680

Figure 4.

Figure 4.

Kaplan-Meier curves of the 3 coprimary outcomes at 11 months after randomization (12-month follow-up). Net adverse clinical events (A), major cardiovascular events (B), and major or clinically relevant nonmajor bleeding (C). abbrev. indicates abbreviated; BARC, Bleeding Academic Research Consortium; DAPT, dual antiplatelet therapy; HR, hazard ratio; MACCE, major adverse cardiac and cerebral events; NACE, net adverse clinical outcomes; and OAC, oral anticoagulation.